Medicare Enrolled
Dr. David Berman, M.D.
Gastroenterology · New York, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Berman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Berman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Berman
Dr. David Berman is a gastroenterology specialist in New York, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Berman performed 1,157 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Berman received a total of $6,549 from 49 pharmaceutical and/or device companies across 377 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Berman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 20% volume in NY
$6,549 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗1,157
Medicare services
Top 20% in NY for gastroenterology
Not available
Unique patients (not deduplicated)
$66
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
202 | $70 | $220 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
176 | $107 | $280 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
125 | $44 | $150 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
105 | $10 | $75 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
73 | $22 | $125 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
73 | $67 | $95 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
73 | $149 | $350 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
68 | $47 | $182 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
54 | $35 | $110 |
| SARS-CoV-2 immunoassay test A laboratory test using immunoassay techniques to detect the presence of severe acute respiratory syndrome coronavirus. |
49 | $35 | $100 |
| Upper GI endoscopy with biopsy A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities. |
32 | $112 | $1,000 |
| Colonoscopy with biopsy A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease. |
27 | $153 | $1,000 |
| Influenza virus detection test A laboratory test that uses an immunoassay technique to detect the presence of the influenza virus through direct visual observation. |
22 | $16 | $70 |
| Strep A rapid test A rapid test to detect Group A Streptococcus bacteria using an immunoassay method with direct visual observation. |
21 | $16 | $50 |
| Annual depression screening | 19 | $20 | $20 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
15 | $31 | $65 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
12 | $87 | $325 |
| Initial preventive physical examination, new Medicare beneficiary A comprehensive preventive health visit for new Medicare beneficiaries during their first 12 months of enrollment. The service is conducted as a face-to-face visit and is limited to preventive care. |
11 | $191 | $250 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$6,549
Total received (2018-2024)
Avg $936/year across 7 years
Top 28% in NY for gastroenterology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
49
Companies
377
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$916
2023
$1,007
2022
$1,364
2021
$874
2020
$601
2019
$1,001
2018
$785
Payments by company (2024)
ABBVIE INC.
$279
PFIZER INC.
$173
QOL Medical, LLC
$102
Lilly USA, LLC
$59
Kiniksa Pharmaceuticals International, plc
$56
Merck Sharp & Dohme LLC
$38
Novo Nordisk Inc
$37
IDORSIA PHARMACEUTICALS US INC
$33
Ambu Inc.
$24
MEDICOMP INC
$23
Intra-Sana Laboratories
$22
Novartis Pharmaceuticals Corporation
$21
Daiichi Sankyo Inc.
$18
Intercept Pharmaceuticals, Inc.
$15
Phathom Pharmaceuticals, Inc.
$15
Top 3 companies account for 60.4% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$847
QOL Medical, LLC
$832
Ferring Pharmaceuticals Inc.
$522
ABBVIE INC.
$397
PFIZER INC.
$253
Novo Nordisk Inc
$250
Amarin Pharma Inc.
$250
Gilead Sciences, Inc.
$250
GlaxoSmithKline, LLC.
$240
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$207
Biogen, Inc.
$192
Takeda Pharmaceuticals U.S.A., Inc.
$180
AbbVie Inc.
$173
SANOFI-AVENTIS U.S. LLC
$144
Regeneron Healthcare Solutions, Inc.
$137
Celgene Corporation
$121
Vertical Pharmaceuticals, LLC
$120
Boehringer Ingelheim Pharmaceuticals, Inc.
$113
Novartis Pharmaceuticals Corporation
$106
Lilly USA, LLC
$102
IDORSIA PHARMACEUTICALS US INC
$102
MEDICOMP INC
$93
Boston Scientific Corporation
$81
Esperion Therapeutics, Inc.
$76
Intercept Pharmaceuticals, Inc.
$72
Kiniksa Pharmaceuticals International, plc
$56
INTERCEPT PHARMACEUTICALS, INC.
$50
Biohaven Pharmaceutical Holding Company Ltd.
$50
AbbVie, Inc.
$44
GENZYME CORPORATION
$42
Janssen Pharmaceuticals, Inc
$41
Merck Sharp & Dohme LLC
$38
Eisai Inc.
$37
Corium, LLC
$36
Genentech USA, Inc.
$33
Braintree Laboratories, Inc.
$31
Bayer HealthCare Pharmaceuticals Inc.
$25
Ambu Inc.
$24
Intra-Sana Laboratories
$22
Linus Health, Inc.
$22
Daiichi Sankyo Inc.
$18
RedHill Biopharma Inc.
$18
Assertio Therapeutics, Inc.
$17
W. L. Gore & Associates, Inc.
$17
Phathom Pharmaceuticals, Inc.
$15
Biohaven Pharmaceuticals, Inc.
$14
AstraZeneca Pharmaceuticals LP
$13
Bausch Health US, LLC
$12
DePuy Synthes Sales Inc.
$12
Top 3 companies account for 33.6% of all-time payments
Associated products mentioned in payments ›
ADLARITY · ADUHELM · APLENZIN · AUBAGIO · Adempas · Aimovig · Arcalyst · BREZTRI · Belviq · CAMBIA · CIMZIA · CLENPIQ · CORE COGNITIVE EVALUATION · CREON · Corlanor · DIVIGEL · Dayvigo · Dexilant · ELIQUIS · GILENYA · GORE CARDIOFORM Septal Occluder · General - EndoChoice · General - GI Dilatation · INJECTAFER · JARDIANCE · LEQVIO · LINZESS · METHYLPHENIDATE 72 · MOUNJARO · MULTAQ · Mavyret · NEXLETOL · NURTEC ODT · OCALIVA · ORTHOVISC · OSMOLEX ER · PRALUENT · PREPOPIK · PREVNAR 20 · Prolia · QULIPTA · QUVIVIQ · RELTONE 200 MG · RINVOQ · Repatha · SHINGRIX · SKYRIZI · SUCRAID · SUTAB · Sucraid · TELEPATCH CARDIAC MONITOR · TRELEGY ELLIPTA · TRULANCE · TRULICITY · Talicia · Trintellix · UBRELVY · UCERIS TABLETS · VERQUVO · VIBERZI · VOQUEZNA · VYVANSE · Vascepa · Wegovy · XARELTO · XIFAXAN · Xofluza · ZEPOSIA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Gastroenterologists in nearby ZIP areas
1,245
County median income
$104,553
Nearest hospital to ZIP centroid (approximate)
LENOX HILL HOSPITAL
0.3 mi
0.3 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Berman is a clinical cardiology specialist, with above-average Medicare volume (top 20% in NY), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Berman experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Berman performed 202 office visit, established patient (20-29 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Berman receive payments from pharmaceutical companies?
Yes. Dr. Berman received a total of $6,549 from 49 companies across 377 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Berman's costs compare to other gastroenterologists in New York?
Dr. Berman's average Medicare payment per service is $66. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Berman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Gastroenterology
Common procedures, typical costs, and what industry payments mean in gastroenterology.
Same specialty & city
Gastroenterologists in New York
Browse gastroenterologists in New York ranked by procedure volume and transparency data.
Highest volume
Top Gastroenterologists in NY
Gastroenterologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Gastroenterologists in NY
Which NY gastroenterologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
QOL Medical, LLC Payments to Doctors
See all physicians who received payments from QOL Medical, LLC.
By company
Ferring Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Ferring Pharmaceuticals Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology